The Neuromuscular Disease Network for Canada

funder-logos_nmd4c

Upcoming webinar: SMA Academy – Hot Topics in Basic SMA Research

NMD4C and Biogen are pleased to invite you to our SMA Academy session on Hot Topics in Basic SMA Research, chaired by NMD4C steering committee member Dr. Rashmi Kothary.

Tuesday, Sept. 22 at 5:00pm ET

The SMA Academy has been developed in partnership with Biogen. The content and design of the presentations are created entirely by the individual speakers, and any potential conflicts of interest will be disclosed. The opinions presented are those of the presenters and are not necessarily those of Biogen Canada Inc.

If you have any questions, please email


Register HERE


Objectives:

  1. Discuss the latest scientific research on the systemic nature of SMA
  2. Discuss the role of biomarkers in characterization of SMA severity and response to treatment
  3. Discuss the metabolic implications of SMA

Topics and speakers:

Lost in translation: The systemic features of SMA

Dr. Marc-Olivier Deguise

Using pre-clinical models to better understand metabolic demands and nutritional support in SMA

Dr. Melissa Bowerman

Biomarkers in SMA

Dr. Robin Parks

Panel discussion led by Dr. Rashmi Kothary

Screenshot 2020-09-11 094906

Read next...

JND-cover

Latest edition of the Journal of Neuromuscular Diseases now online – Sep 2020

A new issue of the Journal of Neuromuscular Diseases has recently been released: Volume 7, Issue 4 (Sep 2020)

Clinical-Guidelines-Register-Now-1200x1200

CME-accredited webinar | Interdisciplinary guidelines for myotonic dystrophy type 1 (DM1) management across the spectrum

NMD4C and MDC are pleased to invite you to a CME-accredited webinar on interdisciplinary guidelines for myotonic dystrophy type 1 (DM1).

stacey

NMD4C steering committee member Stacey Lintern appointed CEO of Muscular Dystrophy Canada

We are happy to congratulate our steering committee member Stacey Lintern for her recent appointment as CEO of our partner organization Muscular Dystrophy Canada (MDC)!

WMS-Challenge-Facebook-1200x1200-white-teal (1)

World Muscle Society “25 Challenge” to support Muscular Dystrophy Canada

Many neuromuscular specialists and members of multidisciplinary neuromuscular teams in Canada are part of the World Muscle Society (WMS). Because people living with neuromuscular conditions have been hit particularly hard by the COVID-19 pandemic, WMS has asked all WMS2020 Congress attendees to get involved by taking on their very own WMS25 Challenge to raise money and awareness for relevant charities across the world. Muscular Dystrophy Canada (MDC), a funder and partner of NMD4C, has been selected as the neuromuscular organization of choice for Canada.

email-3249062_1280

September 2020 newsletter

Topics include Muscular Dystrophy Awareness Month, our new blog featuring NMD4C’s early career members, our recent advocacy work, recent and upcoming webinars, new research from NMD4C participants, and a member spotlight on steering committee member Dr. Rashmi Kothary.

file

Upcoming webinar: Genomics 101

NMD4C and MDC are pleased to invite you to a CME-accredited webinar on September 1st, 2020 about genomics.